Norwest Venture Partners — 2022 Investments
4 investments dated 2022 · listed companies and verified rows first · show all
Kwun Tong, Kowloon
Hareesh RamannainSIMON SUN(Executive Officer)PAT SEK YUEN CHAN(Executive Officer, Director)ANTHONY K. CHAN(Executive Director of Finance and US Operations)HEUNG SANG ADDY (DEXTER) FONG(Class II Director)HAREESH RAMANNA(Executive Officer)
Co-investorsAccelPartners for GrowthPartners for Growth (PFG)
Rezo Therapeutics is a drug discovery and development company focused on oncology and inflammation therapeutic areas.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Nevan Krogan(Co-Founder)Sourav Bandyopadhyay(Co-Founder)Norbert Bischofberger(Co-Founder)Natalia Jura(Co-Founder)George Scangos(Co-Founder)Kevan Shokat(Co-Founder)
Board seatTiba Aynechi· per SEC Form D
Co-investorsAndreessen HorowitzHAWKTAILValkyrie Ventures Management, LlcARCH Venture PartnersSR One Capital Management
HealthtechNashville, US
MICHAEL UCHRIN(Executive Officer, Director)CHRIS CHI(Executive Officer)
BoardWILLIAM FRIST(Director)CHRISTOPHER BOOKER(Director)
Board seatCasper de Clercq· per SEC Form D · $425M raise · filed Jan 2023
Anonym provides privacy-focused advertising technology that enables advertisers and platforms to measure performance and optimize campaigns without exposing user data.
AdTechPalo Alto, US
Graham Mudd(Director)Bradley Smallwood(Executive Officer, Director)
BoardPaul Sanderson(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.